The results revealed that these targets were closely associated with the PI3K-AKT pathway, EGFR tyrosine kinase inhibitor resistance, endocrine resistance and MAPK signaling, and pancreatic cancer, which may improve the understanding of the molecular mechanism associated with pancreatic cancer progression (Figure 7). This evidence concerns the gene AKT1 and familial pancreatic carcinoma.